Results 151 to 160 of about 7,254 (221)

Real-world outcome and dose intensity of Pola-R-CHP versus R-CHOP/R-THP-COP in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective cohort study. [PDF]

BMC Cancer
Fujita K, Kajiya K, Lee S, Morishita T, Nonogaki S, Miwa N, Hara T, Tsurumi H.   +7 more
europepmc   +1 more source

Impact of Cellular Senescence on LCN2 Expression in Salivary Gland Epithelial Cells and Oral Keratinocytes. [PDF]

Biofactors
Shikama Y, Yoshida K, Shikama Y.
europepmc   +1 more source

Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study. [PDF]

Ann Hematol
Yamada T, Nakamura N, Goto H, Hara T, Kasahara S, Fukuno K, Sawada M, Nakamura H, Hayase N, Goto T, Suzaki T, Fujita K, Lee S, Kanemura N, Shimizu M, Tsurumi H.   +15 more
europepmc   +1 more source

Nanoscale zinc for sustainable groundnut growth: an eco-conscious molecular approach. [PDF]

Sci Rep
Ashwini MN, Gajera HP, Hirpara DG, Parakhia MV.   +3 more
europepmc   +1 more source

From Spheroids to Tumor-on-a-Chip for Cancer Modeling and Therapeutic Testing. [PDF]

Micromachines (Basel)
Lipreri MV, Totaro MT, Baldini N, Avnet S.   +3 more
europepmc   +1 more source

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma. [PDF]

Cardiooncology
Ulfstedt JM, Risebro R, Freyhult E, Christersson C, Mörth C, Kamali-Moghaddam M, Robelius A, Enblad G, Molin D.   +8 more
europepmc   +1 more source

Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma. [PDF]

Oncogene
Esaki N, Sakoda T, Ando R, Miyai Y, Iida T, Mizutani Y, Yoshida M, Hara Y, Matsuyama M, Kobayashi T, Shiraki Y, Mii S, Ichikawa J, Kawasaki T, Manabe S, Sakai T, Nishida Y, Takahashi M, Enomoto A.   +18 more
europepmc   +1 more source

Harnessing evolution: leveraging bacterial isoprenoid pathway diversity toward improved bioengineering strategies. [PDF]

J Bacteriol
Qabar CM, Marshall BA, Landick R, Cox JS.   +3 more
europepmc   +1 more source

Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells. [PDF]

EJNMMI Res
Damiana TST, van den Brink L, de Kreij-de Bruin LW, Stuurman DC, de Ridder CMA, Dalm SU.   +5 more
europepmc   +1 more source

The mevalonate pathway of isoprenoid biosynthesis supports metabolic flexibility in <i>Mycobacterium marinum</i>. [PDF]

J Bacteriol
Qabar CM, Baidoo EE, Akyuz Turumtay E, Qayum TM, Keasling JD, Madigan CA, Portnoy DA, Cox JS.   +7 more
europepmc   +1 more source